Ongoing Phase 2 study enrolling 102 patients in the U.S. and South Korea, with more than 50% of participants identified as Asian ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...

Congressional Republicans are investigating Nashville Mayor Freddie O'Connell's response to immigration arrests during ...

BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating initiatives including the integration and disposition of assets acquired in ...

The fact that the COVID-19 vaccine is not available for newborn babies is shielding a group of prisoners on Georgia's death ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Get Ready is proud to launch the 'Become a Willing Bystander' Program in support of the Stevenson Memorial Hospital ...

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug ...